The goal of this pilot randomized controlled trial (RCT) is to examine donor human milk (DHM) as a clinical intervention targeted at achieving beneficial microbiome signatures in full-term infants who are exposed to intrapartum antibiotic prophylaxis (IAP) therapy during labour. Secondarily, this study aims to compare the infant health outcomes of sleep and growth between groups to assess if these outcomes are mediated by infant feeding type or potential differences in microbial signatures. Finally, this study will compare maternal outcomes of depression, anger, breastfeeding self-efficacy and breastfeeding rates between groups. The hypothesis of this study is: that replacing formula with DHM supplementation will minimize gut microbiome dysbiosis and foster homeostasis following supplementation. In addition, it is hypothesized that improved homeostasis will promote improved sleep and growth outcomes in participant infants. Finally, mothers whose infants receive DHM will have lower depression and anger scores and high breastfeeding self-efficacy and exclusive breastfeeding rates compared to mothers whose infants receive formula.
Age range
37 Weeks
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Infant gut microbiome - shallow shotgun metagenomics (RA)
Timeframe: one week postpartum
Infant gut microbiome - shallow shotgun metagenomics (RA)
Timeframe: six weeks postpartum
Infant gut microbiome - shallow shotgun metagenomics (RA)
Timeframe: twelve weeks postpartum
Infant gut microbiome - shallow shotgun metagenomics (alpha diversity)
Timeframe: one week postpartum
Infant gut microbiome - shallow shotgun metagenomics (alpha diversity)
Timeframe: six weeks postpartum
Infant gut microbiome - shallow shotgun metagenomics (alpha diversity)
Timeframe: twelve weeks postpartum
Infant gut microbiome - shallow shotgun metagenomics (beta diversity)
Timeframe: one week postpartum
Infant gut microbiome - shallow shotgun metagenomics (beta diversity)
Timeframe: six weeks postpartum
Infant gut microbiome - shallow shotgun metagenomics (beta diversity)
Timeframe: twelve weeks postpartum